← Back to Analyst Consensus 
MOLN Buy
MOLECULAR PARTNERS AG
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Apr 22, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 16, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jan 27, 2026 | HC Wainwright & Co. | initiate | — → Buy | $13 | 44% |
| Dec 8, 2025 | JP Morgan | maintain | Neutral → Neutral | $3.75 | 54% |
| Sep 3, 2025 | JP Morgan | maintain | Neutral → Neutral | $4 | 54% |
| Mar 11, 2025 | LifeSci Capital | initiate | — → Outperform | $12 | 57% |
| Dec 5, 2023 | JP Morgan | maintain | Neutral → Neutral | $4.5 | 54% |
| Aug 29, 2022 | SVB Leerink | downgrade | Outperform → Market Perform | $8 | — |
| May 25, 2022 | Credit Suisse | upgrade | Underperform → Neutral | $0 | — |
| Apr 27, 2022 | SVB Leerink | maintain | — → Outperform | $29 | — |
| Jan 14, 2022 | SVB Leerink | maintain | — → Outperform | $42 | — |
| Aug 27, 2021 | SVB Leerink | maintain | — → Outperform | $35 | — |
| Jul 13, 2021 | Cowen & Co. | initiate | — → Outperform | $50 | — |
Price Target Trend
Mar 30, 2026 Latest: $10.49 Oct 24, 2026
EPS Estimates
+1q $-0.22
Lo: $-0.22 Hi: $-0.22
1 analysts ▲1
0q $-0.34
Lo: $-0.34 Hi: $-0.34
1 analysts 0y $-1.11
Lo: $-1.46 Hi: $-0.65
3 analysts ▲1
+1y $-0.14
Lo: $-1.33 Hi: $1.81
3 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days